Atomic resolution structure of full-length human insulin fibrils
Proceedings of the National Academy of Sciences · 04.06.2024 · 121 (23)
DOI: 10.1073/pnas.2401458121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 29.05.2024. Verfasst von Saba Suladze und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bavarian Nuclear Magnetic Resonance Center at the Department of Biosciences, School of Natural Sciences, Technische Universität München, Garching 857…. Hauptthemen laut MEDLINE: Amyloid, Insulin. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Patients with type 1 diabetes mellitus who are dependent on an external supply of insulin develop insulin-derived amyloidosis at the sites of insulin injection. A major component of these plaques is identified as full-length insulin consisting of the two chains A and B. While there have been several reports that characterize insulin misfolding and the biophysical properties of the fibrils, atomic-level information on the insulin fibril architecture remains elusive. We present here an atomic resolution structure of a monomorphic insulin amyloid fibril that has been determined using magic angle spinning solid-state NMR spectroscopy. The structure of the insulin monomer yields a U-shaped fold in which the two chains A and B are arranged in parallel to each other and are oriented perpendicular to the fibril axis. Each chain contains two β‐strands. We identify two hydrophobic clusters that together with the three preserved disulfide bridges define the amyloid core structure. The surface of the monomeric amyloid unit cell is hydrophobic implicating a potential dimerization and oligomerization interface for the assembly of several protofilaments in the mature fibril. The structure provides a starting point for the development of drugs that bind to the fibril surface and disrupt secondary nucleation as well as for other therapeutic approaches to attenuate insulin aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bavarian Nuclear Magnetic Resonance Center at the Department of Biosciences, School of Natural Sciences, Technische Universität München, Garching 85747, Germany.
- Helmholtz-Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Institute of Structural Biology, Neuherberg 85764, Germany.
- Sanofi-Aventis Deutschland GmbH, Diabetes Research, Industriepark Höchst, Frankfurt 65926, Germany.
- Sanofi-Aventis Deutschland GmbH, Manufacturing Science and Technology, Industriepark Höchst, Frankfurt 65926, Germany.
- Chemistry Manufacturing & Controls Microbial Platform, Sanofi-Aventis Deutschland GmbH, Microbial Platform, Industriepark Höchst, Frankfurt 65926, Germany.
- Sanofi-Aventis Deutschland GmbH, Tides Platform, Industriepark Höchst, Frankfurt 65926, Germany.
ORCID-Profile: Saba Suladze, Riddhiman Sarkar, Natalia Rodina, Krister Bokvist, Manuel Krewinkel, Daniel Scheps, Norbert Nagel, Benjamin Bardiaux, Bernd Reif
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Suladze, S., Sarkar, R., Rodina, N., Bokvist, K., Krewinkel, M., Scheps, D., Nagel, N., Bardiaux, B., & Reif, B. (2024). Atomic resolution structure of full-length human insulin fibrils. Proceedings of the National Academy of Sciences, 121(23). https://doi.org/10.1073/pnas.2401458121
Vancouver
Suladze S, Sarkar R, Rodina N, Bokvist K, Krewinkel M, Scheps D, et al. Atomic resolution structure of full-length human insulin fibrils. Proceedings of the National Academy of Sciences. 2024;121(23). doi:10.1073/pnas.2401458121
BibTeX
@article{Suladze2024,
author = {Suladze, Saba and Sarkar, Riddhiman and Rodina, Natalia and Bokvist, Krister and Krewinkel, Manuel and Scheps, Daniel and Nagel, Norbert and Bardiaux, Benjamin and Reif, Bernd},
title = {Atomic resolution structure of full-length human insulin fibrils},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {23},
doi = {10.1073/pnas.2401458121}
}
EUVIMED